Skip to main content

Table 1 Demographic information of the study participants

From: Topological DNA damage, telomere attrition and T cell senescence during chronic viral infections

Subjects

Numbers

Age (Mean)

Gender (M/F)

Viral load and other characteristics

HCV

37

31–69 (52)

29/8

17,000-9,980,000 IU/ml, 26 GT1, 6 GT2, 5 GT3

HBV

29

22–61 (49)

20/9

All on antivirals with undetectable HBV-DNA

HIV

28

25–62 (46)

21/7

All on ART with undetectable HIV-RNA

HS

144

24–58 (44)

112/32

All tested negative for HCV, HBV, and HIV